Acute Mania
Lithium, valproate and several antipsychotics may be used. Severe agitation or psychosis may require combination treatment and hospitalization.
Bipolar Disorder, Mania, Depression and Long-Term Monitoring
Mood Stabilizers Explained: Benefits, Long-Term Risks and Biochemical Considerations
Mood stabilizers are used to control mania, reduce mood cycling, treat selected forms of bipolar depression and prevent future episodes. The medications grouped under this name differ substantially in their benefits, risks and monitoring requirements.
The best mood stabilizer depends on the phase of illness. A medication that is effective for acute mania may not be the strongest treatment for bipolar depression, while a medication that prevents depressive relapse may be inadequate during dangerous mania.
What Is a Mood Stabilizer?
The term mood stabilizer is used for medications that treat or prevent episodes of mania, hypomania, bipolar depression or recurrent mood cycling without consistently pushing the patient toward the opposite mood state.
The term does not refer to one pharmacological class. Lithium is a mineral salt. Lamotrigine, valproate and carbamazepine were originally developed as antiseizure medications. Several atypical antipsychotics are also used for acute or maintenance treatment of bipolar disorder.
“Mood stabilizer” does not mean that every medication treats every phase equally. Treatment should match the current problem: acute mania, mixed symptoms, bipolar depression or prevention of future episodes.
Which Medications Are Used as Mood Stabilizers?
| Medication | Common clinical role | Potential strengths | Important monitoring or risks |
|---|---|---|---|
| Lithium | Acute mania, maintenance treatment and prevention of recurrent bipolar episodes | Strong long-term evidence and may benefit both manic and depressive recurrence in selected patients | Serum level, kidney function, thyroid, calcium, electrolytes, hydration and medication interactions |
| Lamotrigine | Maintenance treatment with particular value in preventing depressive recurrence | Generally less weight gain, sedation and metabolic burden than several alternatives | Slow titration and immediate assessment of rash because of rare serious skin reactions |
| Valproate / divalproex | Acute mania, mixed presentations and maintenance in selected patients | Often useful when mania includes agitation, rapid cycling or mixed symptoms | Liver, CBC, platelets, weight, metabolic effects, pancreatitis, ammonia and major fetal risks |
| Carbamazepine | Acute mania, mixed symptoms and selected treatment-resistant presentations | May help patients who do not respond adequately to other antimanic medications | CBC, liver, sodium, drug interactions, serious skin reactions and rare bone-marrow toxicity |
| Atypical antipsychotics | Acute mania, bipolar depression or maintenance depending on the specific medication | Often act more rapidly during severe mania, agitation or psychosis | Weight, glucose, lipids, movement effects, sedation, prolactin and cardiovascular effects |
Which Mood Stabilizer Is Best for Mania or Bipolar Depression?
There is no single best medication for every bipolar patient. The current phase, previous response, severity, psychosis, suicide risk, kidney and liver status, pregnancy potential and long-term goals all matter.
Mixed Features
Depression occurring with racing thoughts, agitation, reduced sleep or impulsivity may respond differently from uncomplicated bipolar depression.
Bipolar Depression
Lamotrigine and selected atypical antipsychotics may be considered, while antidepressants require caution because of activation risk.
Maintenance Treatment
The goal is to prevent both poles while preserving cognition, physical health, relationships, work and normal daily function.
A Practical Medication-Selection Sequence
Identify the current mood phase
Assess safety, psychosis and sleep
Review prior benefits and adverse effects
Consider organ function and pregnancy risk
Choose acute and long-term treatment goals
How Does Lithium Work in Bipolar Disorder?
Lithium has been used for decades as a treatment for mania and recurrent bipolar disorder. Its actions are complex and include effects on intracellular signaling, ion transport, glycogen-synthase-kinase pathways, neuroplasticity and circadian regulation.
Lithium can be highly effective, but the therapeutic and toxic concentrations are close enough that blood-level monitoring is essential. Kidney function, thyroid function, electrolytes, vital signs, current medications and pregnancy status should be reviewed before treatment. :contentReference[oaicite:0]{index=0}
Potential Benefits
Reduced mania, fewer recurrent episodes, improved sleep and reduced mood cycling in appropriately selected patients.
Common Side Effects
Tremor, thirst, frequent urination, nausea, diarrhea, fatigue, cognitive slowing, acne and weight change may occur.
Signs of Possible Toxicity
Worsening tremor, vomiting, diarrhea, marked weakness, confusion, slurred speech, poor coordination or severe drowsiness require prompt assessment.
Why do dehydration and medications affect lithium levels?
Lithium is handled by the kidneys in relation to sodium and fluid balance. Dehydration, vomiting, diarrhea, low sodium intake, fever or major dietary changes may raise lithium exposure.
Diuretics, nonsteroidal anti-inflammatory drugs and selected blood-pressure medications can also increase lithium levels or toxicity risk. Every new prescription and over-the-counter pain medication should be considered in the lithium review.
Can Long-Term Lithium Damage the Kidneys?
Lithium can impair the kidney’s ability to concentrate urine, producing excessive thirst and urination. Long-term therapy may also be associated with progressive kidney impairment in some patients, although the degree of risk varies.
FDA labeling recommends assessing kidney function before and during lithium therapy. Progressive or sudden changes in renal function warrant reassessment of lithium exposure, other medications and the continuing risk-benefit balance. :contentReference[oaicite:1]{index=1}
Serum creatinine and eGFR
Follow trends rather than relying only on one isolated result.
Urinalysis and urine albumin
May provide evidence of kidney injury not fully reflected by
creatinine.
Urine volume and concentrating ability
Persistent excessive thirst and urination may indicate impaired tubular
function.
Cystatin C
May add context when low muscle mass makes creatinine-based estimates
less reliable.
Medication interactions
Diuretics, NSAIDs and selected antihypertensives may alter lithium
clearance.
Hydration and sodium balance
Illness, heat, fasting and dietary changes may alter lithium exposure.
Kidney decline does not mean lithium should be stopped abruptly
Sudden discontinuation can destabilize bipolar illness. The current kidney findings, lithium benefit, alternative treatments and relapse history should be reviewed with psychiatry and, when appropriate, nephrology.
How Does Lithium Affect the Thyroid and Calcium?
Lithium may contribute to hypothyroidism or thyroid enlargement in susceptible patients. Thyroid function should be monitored during stabilization and maintenance treatment. Hypothyroidism may sometimes be treated while lithium is continued when lithium remains clinically valuable. :contentReference[oaicite:2]{index=2}
Lithium can also affect parathyroid function and calcium regulation. Persistent calcium elevation may require additional evaluation of parathyroid hormone, kidney function, vitamin D and bone health.
TSH
Free T4
Calcium
Parathyroid hormone when indicated
Vitamin D
Kidney function
How Is Lamotrigine Used in Bipolar Disorder?
Lamotrigine is used primarily for maintenance treatment of bipolar I disorder and is often selected when prevention of depressive episodes is a major goal. It is generally not relied upon as the sole rapid treatment for severe acute mania.
Lamotrigine is often attractive because it usually causes less weight gain, sedation and metabolic burden than several other mood-stabilizing medications.
Potential Advantages
May help prevent depressive recurrence while preserving alertness, weight and metabolic function.
Common Side Effects
Dizziness, headache, blurred or double vision, nausea, coordination difficulty and sleep changes may occur.
Slow Titration
The dose is increased gradually because rapid titration and selected medication combinations increase serious-rash risk.
Any new rash requires prompt clinical review
Lamotrigine can cause rare but serious skin reactions requiring hospitalization and discontinuation. The risk is greater with excessive starting doses, rapid titration or concurrent valproate. A rash should not be assumed harmless without appropriate assessment. :contentReference[oaicite:3]{index=3}
Mouth sores, fever, facial swelling, blistering, peeling skin, eye irritation or systemic illness accompanying a rash are particularly concerning.
How Are Valproate and Depakote Used?
Valproic acid and divalproex are used for acute mania and selected maintenance treatment, particularly when symptoms include agitation, rapid cycling or mixed features.
Potential Benefits
May reduce manic activation, agitation, aggression, rapid thoughts and mixed mood symptoms.
Common Side Effects
Weight gain, tremor, sedation, nausea, hair changes, bruising and metabolic effects may occur.
Laboratory Concerns
Liver injury, platelet reduction, pancreatitis and elevated ammonia require clinical and laboratory awareness.
Baseline and follow-up monitoring commonly includes liver tests, CBC, platelets, weight and medication levels when clinically useful.
Valproate carries major pregnancy and fetal-development risks
Current FDA labeling states that valproate should not be used for bipolar disorder in patients who are pregnant or planning pregnancy unless other medications have failed or are otherwise unacceptable. Risks include major congenital malformations, neural-tube defects, decreased IQ and neurodevelopmental disorders. :contentReference[oaicite:4]{index=4}
What is valproate-related hyperammonemia?
Valproate can increase ammonia, sometimes even when routine liver tests are not dramatically abnormal. New lethargy, vomiting, confusion, cognitive decline or reduced consciousness may warrant ammonia testing and urgent medication review.
Carnitine metabolism may be relevant in selected cases of valproate toxicity or hyperammonemia, but supplementation should be matched to the clinical situation rather than added routinely without review.
How Is Carbamazepine Used as a Mood Stabilizer?
Carbamazepine may be used for acute manic or mixed episodes and selected treatment-resistant bipolar presentations. It has substantial drug-interaction and laboratory-monitoring requirements.
Potential Benefits
May reduce manic activation, irritability and mixed symptoms in selected patients.
Common Side Effects
Dizziness, sedation, nausea, double vision, poor coordination and cognitive slowing may occur.
Drug Interactions
Carbamazepine affects liver enzymes and can lower the concentrations of numerous medications, including hormonal contraceptives.
Monitoring may include CBC, liver tests, sodium and medication levels. Carbamazepine has boxed warnings for aplastic anemia and agranulocytosis, although these events remain uncommon. :contentReference[oaicite:5]{index=5}
Serious skin reactions and ancestry-related genetic risk
Carbamazepine can cause Stevens-Johnson syndrome and toxic epidermal necrolysis. Genetic screening may be appropriate before treatment in patients with ancestry associated with higher prevalence of relevant HLA variants.
Why is sodium monitored?
Carbamazepine may contribute to hyponatremia. Low sodium can cause headache, fatigue, confusion, unsteadiness, falls, seizures or apparent psychiatric deterioration.
Why Are Antipsychotics Used as Mood Stabilizers?
Several atypical antipsychotics are used for acute mania, bipolar depression or maintenance treatment. They may act more rapidly than lithium or lamotrigine during severe agitation, psychosis or insomnia.
Rapid Symptom Control
May reduce psychosis, dangerous agitation, severe insomnia and manic behavioral escalation.
Bipolar Depression
Selected atypical antipsychotics have evidence or approval for bipolar depressive episodes.
Maintenance Treatment
Some may be continued to prevent relapse when benefits remain greater than metabolic, movement or cognitive risks.
Long-term monitoring may include weight, waist circumference, blood pressure, fasting glucose or A1c, lipids, movement symptoms and prolactin when clinically relevant.
Why Can Antidepressants Destabilize Bipolar Disorder?
Antidepressants may help selected bipolar patients, but they can also contribute to activation, mixed symptoms, rapid cycling, hypomania or mania in susceptible individuals.
Warning signs after starting or increasing an antidepressant include:
- Markedly reduced need for sleep
- Racing thoughts or unusually rapid speech
- New impulsive spending or risky behavior
- Grandiosity or excessive confidence
- Severe irritability or aggression
- Multiple unrealistic projects
- Psychosis or loss of judgment
Feeling more energetic is not always recovery. Productive improvement usually includes better judgment, stable sleep and improved function. Escalating energy with less sleep and poorer judgment may indicate activation.
Related reading: Choosing the Correct Antidepressant and What Causes Bipolar Disorder? .
Which Mood Stabilizers Require Special Pregnancy Planning?
Pregnancy planning should occur before conception whenever possible. Risks vary by medication, dose, timing and the danger of untreated bipolar illness.
Valproate
Carries particularly serious fetal and neurodevelopmental risks and should generally be avoided when safer effective alternatives are available.
Carbamazepine
May increase congenital-malformation risk and can reduce hormonal contraceptive effectiveness through drug interactions.
Lithium
Requires individualized risk assessment, dose and level monitoring, especially as kidney handling changes during pregnancy and delivery.
Lamotrigine
May be considered in selected patients, but drug levels and clinical response can change substantially during pregnancy.
Do not stop a mood stabilizer after discovering pregnancy without medical guidance
Abrupt discontinuation may provoke severe mania, depression, psychosis or hospitalization. Contact the prescribing clinician promptly for an individualized plan.
Which Long-Term Mood-Stabilizer Side Effects Matter Most?
Kidney effects
Particularly important with lithium and with any medication whose dose
depends on renal clearance.
Thyroid and calcium effects
Lithium may affect thyroid and parathyroid function.
Weight and metabolic effects
Valproate and several antipsychotics may contribute to weight gain,
insulin resistance and lipid abnormalities.
Liver effects
Valproate and carbamazepine require attention to liver function and
symptoms of hepatic injury.
Blood-count effects
Platelets may fall with valproate; carbamazepine can rarely cause severe
bone-marrow suppression.
Cognitive effects
Sedation, slowed thinking, tremor and reduced coordination can impair
school, work, driving and rehabilitation.
Skin reactions
Lamotrigine and carbamazepine can cause rare but serious reactions.
Reproductive effects
Pregnancy risk, contraception interactions and hormone-related effects
require anticipatory discussion.
Which Laboratory Tests Are Used With Mood Stabilizers?
| Test | Medication relevance | What it may identify |
|---|---|---|
| Serum lithium level | Lithium | Whether exposure is within the clinician’s intended therapeutic range or approaching toxicity |
| Creatinine, eGFR, cystatin C and urinalysis | Lithium and other renally cleared medications | Kidney filtration, tubular effects and evolving renal impairment |
| TSH and free T4 | Lithium | Hypothyroidism or changing thyroid function |
| Calcium and parathyroid hormone when indicated | Lithium | Hypercalcemia and possible parathyroid dysfunction |
| CBC and platelets | Valproate and carbamazepine | Platelet reduction, anemia, leukopenia or rare marrow toxicity |
| Liver enzymes and bilirubin | Valproate and carbamazepine | Hepatic stress or injury |
| Serum sodium | Carbamazepine and other contributing medications | Hyponatremia that may present with confusion or neurological symptoms |
| Valproate or carbamazepine level | Selected patients | Medication exposure, adherence, interactions or suspected toxicity |
| Ammonia | Valproate when clinically indicated | Hyperammonemia in patients with lethargy, vomiting, confusion or reduced consciousness |
| Glucose, A1c, insulin and lipids | Valproate and atypical antipsychotics | Weight-related metabolic effects and insulin resistance |
| Pregnancy testing when appropriate | Valproate, carbamazepine, lithium and other relevant drugs | Supports safe medication planning before fetal exposure |
How Can Walsh and Functional Testing Add to Bipolar Treatment?
Laboratory-guided nutrient treatment is not a substitute for necessary mood stabilization. It may identify biochemical contributors that increase vulnerability to depression, activation, insomnia, inflammation or medication side effects.
Copper and Zinc Balance
Copper-related norepinephrine activity and low zinc may contribute to anxiety, irritability, insomnia and reduced stress tolerance.
Methylation
Whole-blood histamine, homocysteine, SAM and SAH may provide more context than an MTHFR result alone.
Vitamin D and Nutrient Status
Deficiencies may worsen mood, immune function, muscle health and general resilience.
Mitochondrial and Energy Stress
Low energy reserve, poor sleep, inflammation and glucose instability may increase vulnerability to mood episodes.
Gut and Toxic Burden
Dysbiosis, malabsorption, food-related inflammation and impaired clearance may interfere with nutrient status and medication tolerance.
Hormones and Thyroid
Menstrual, postpartum, menopausal, thyroid and cortisol-related changes may influence cycling, sleep and treatment response.
Bipolar disorder is not diagnosed by a Walsh biotype. Biochemical testing is used to identify contributing patterns and treatment barriers after safety, diagnosis and mood stabilization have been addressed.
Review: The Walsh Approach, What Causes Bipolar Disorder? and laboratory testing.
Can Nutrients Support Mood Stability?
Nutrients affect neurotransmitter metabolism, cellular energy, antioxidant systems, membranes and inflammatory regulation. Selection should be based on measured need and the risk of activation.
Zinc and vitamin B6
May support stress regulation and copper balance when deficiency or
pyroluria-related need is present.
Vitamin D
Supports neurological, immune, bone and muscle health when deficiency
is documented.
Magnesium
Supports energy and neuromuscular regulation, but kidney function and
medication interactions affect safety.
Omega-3 fatty acids
May support membrane and inflammatory physiology as part of a broader
treatment plan.
Creatine
Supports brain and muscle energy and may reduce endogenous methylation
demand.
Protein and amino acids
Provide substrates needed for neurotransmitters, glutathione, creatine,
methylation and tissue repair.
Activating nutrients can destabilize susceptible patients
SAMe, methionine, methylfolate and other activating products may worsen insomnia, agitation, hypomania or mania. They should not be added solely because an MTHFR variant is present.
Stabilize Before Considering Medication Reduction
Mood stabilizers may be essential when there is mania, psychosis, suicidal depression, dangerous impulsivity, severe aggression or an inability to care for basic needs.
The preferred sequence is:
- Stabilize the acute mood episode and protect safety.
- Establish the medication’s benefits and adverse effects.
- Review kidney, liver, thyroid, metabolic and reproductive risks.
- Perform targeted biochemical and nutritional testing.
- Correct deficiencies and functional barriers gradually.
- Optimize the medication regimen when needed.
- Consider gradual reduction only after sustained stability and with the prescribing clinician.
Abrupt discontinuation may provoke mania, depression, psychosis, hospitalization or dangerous behavior. The absence of current symptoms may reflect successful treatment rather than absence of illness.
The Second Opinion Physician Mood-Stabilizer Evaluation
Illness Pattern
- Manic, hypomanic, depressive and mixed episodes
- Sleep and circadian changes
- Psychosis, aggression and suicide risk
- Episode triggers and seasonality
- Family history and previous medication response
Medication Safety
- Kidney, thyroid and calcium monitoring
- Liver, blood-count and sodium monitoring
- Weight, glucose and lipid effects
- Pregnancy and contraceptive considerations
- Drug and supplement interactions
Biochemical Contributors
- Copper, ceruloplasmin and zinc
- Whole-blood histamine
- SAM, SAH and homocysteine
- Vitamin D and nutrient status
- Inflammation, gut and toxic burden
Treatment Priorities
- Maintain psychiatric stability
- Reduce avoidable organ and metabolic risks
- Correct measured nutrient abnormalities
- Improve sleep, exercise, diet and daily structure
- Reassess the lowest effective medication burden over time
Frequently Asked Questions About Mood Stabilizers
What is a mood stabilizer?
A mood stabilizer is a medication used to treat or prevent mania, hypomania, bipolar depression or recurrent mood cycling. Different medications are more effective for different phases of bipolar illness.
What is the best mood stabilizer for bipolar disorder?
There is no single best medication for every patient. Selection depends on whether the problem is acute mania, mixed symptoms, bipolar depression or relapse prevention, as well as prior response, organ function, pregnancy potential and side effects.
Can lithium damage the kidneys?
Lithium may impair urine-concentrating ability and can contribute to declining kidney function in some long-term users. Kidney function, hydration, serum lithium and interacting medications should be reviewed regularly.
Does lithium affect the thyroid?
Yes. Lithium may contribute to hypothyroidism or thyroid enlargement. Thyroid function should be checked before and during treatment.
Why must lamotrigine be increased slowly?
Slow titration reduces the risk of serious skin reactions. Any new rash, particularly with fever, mouth sores, facial swelling, blistering or systemic illness, requires prompt medical assessment.
Is lamotrigine good for acute mania?
Lamotrigine is used mainly for bipolar maintenance and prevention of depressive recurrence. It is generally not relied upon alone for rapid control of severe acute mania.
Why is valproate risky during pregnancy?
Prenatal valproate exposure is associated with neural-tube defects, other major malformations, lower IQ and neurodevelopmental disorders. Pregnancy planning should occur before conception whenever possible.
Why are liver tests and platelets checked with Depakote?
Valproate can cause liver injury and may reduce platelets. New abdominal pain, persistent vomiting, unusual bruising, jaundice or severe lethargy requires prompt review.
Why are sodium and blood counts checked with carbamazepine?
Carbamazepine may lower sodium and can affect blood-cell production. Confusion, unsteadiness, fever, sore throat, unusual bruising or rash requires medical assessment.
Can antidepressants cause mania?
Antidepressants may trigger activation, mixed symptoms, hypomania or mania in susceptible patients. Reduced sleep, racing thoughts, impulsivity and unusual energy require prompt review.
Can nutrients replace a mood stabilizer?
Nutrient treatment may address contributing biochemical abnormalities, but it should not replace necessary medication during mania, psychosis, suicidal depression or dangerous instability.
Can a mood stabilizer be stopped after symptoms improve?
Improvement may reflect successful treatment. Abrupt discontinuation can provoke relapse. Any reduction should occur gradually after sustained stability and under the direction of the prescribing clinician.
Reviewing the Benefits and Long-Term Risks of Mood Stabilizers
A detailed history and laboratory review may clarify kidney, thyroid, liver, metabolic, nutritional and biochemical factors affecting mood stability and medication safety.
Selected Sources and Further Reading
- U.S. Food and Drug Administration. Lithium prescribing information: pretreatment screening, blood-level monitoring, kidney and thyroid considerations.
- U.S. Food and Drug Administration. Lamictal prescribing information: bipolar maintenance treatment and serious-rash warning.
- U.S. Food and Drug Administration. Depakote prescribing information: mania, liver and pancreatic risks, blood-count monitoring and fetal risk.
- U.S. Food and Drug Administration. Tegretol and carbamazepine prescribing information: hematologic, dermatologic, sodium and interaction risks.